KR20120103293A - Method for controlling cell proliferation by using a non-thermal atmospheric pressure plasma exposure - Google Patents

Abstract

PURPOSE: A method for controlling cells growth using low-thermal atmospheric pressure plasma exposure is provided to establish exposure condition. CONSTITUTION: A method for controlling cell growth comprises a step of controlling the condition of low-thermal atmospheric pressure plasma exposure in culturing cells. The condition includes gas inflow, input voltage, cell culture amount, plasma exposing time, distance from a generation source, or plasma exposure frequency. The plasma is generated in an atmospheric pressure plasma of DBD(Dielectric Barrier Discharge). A medium for culturing cells is used for culturing normal cells, stem cells, or cancer cells. [Reference numerals] (AA) Distance from plasma generating source : 2-5 cm; (BB) Standard liter per minute (slm) : 0.2 slm or more; (CC) Source : helium gas (He gas); (DD) Frequency : 20KHz; (EE) Input voltage : 5-12 V; (FF) Output voltage : 6-20 KV

Description

Method for controlling cell proliferation by using a non-thermal atmospheric pressure plasma exposure

The present invention relates to a method for regulating cell growth using cold atmospheric plasma exposure to promote or inhibit growth of normal cells, stem cells, cancer cells, etc. by plasma treatment during cell culture through a cold atmospheric plasma generator capable of irradiating cells. will be.

Plasma is an ionized state of a gas, and under certain conditions, a neutral gas, non-equilibrium, in which electrons and ions remain stable in an unbalanced state. Non-equilibrium plasma has the advantage of being able to surface treatment without damaging the reacting material because it can cause strong chemical reaction only without big energy transfer when interacting with the surface of the object. It is widely used in material surface processing, microelectronics, semiconductor processing and so on.

Plasma has been generated in a vacuum chamber that has been reduced in pressure to make it uniform in a wide area. However, in recent years, plasma can be discharged even at relatively high pressures such as atmospheric pressure by reducing the distance between electrodes. Unlike the vacuum chamber and thus the pump device is not required, the cost required for plasma generation is low, and can be used in the daily gas pressure range, and its application is very high, and it is advantageous in that it can be applied to organic material processing and living body.

In particular, as research on bio-medical applications using atmospheric pressure plasma has begun, interest in the effect of non-equilibrium plasma on human cells or tissues is increasing. However, plasma is known to affect healing of skin damage caused by burns, removal and death of malignant cells such as cancer cells, skin improvement for beauty, and recovery of enamel components of bones and teeth. It has not been studied to induce recovery or death of cancer cells. Only recently, a method for developing an atmospheric low-temperature microplasma spray device for bio-medical applications (Korean Patent Publication No. 2009-0028661), or a method of sterilizing a microorganism-contaminated object using an atmospheric plasma, has been devised (Korea Patent Publication). No. 2009-0021172).

At present, it is very important to develop a microplasma device with an appropriate energy level capable of controlling cell growth at the cellular level without directly applying it to humans, and to study the source technology to understand the interaction mechanism between plasma and human cells.

On the other hand, stem cells have recently been actively studied for adult stem cells, with limitations appearing in the study of embryonic stem cells due to ethical or political issues. Adult stem cells have been mainly focused on bone marrow mesenchymal stem cells (MSCs). Adipose tissue, like bone marrow, is also a mesodermally-derived organ that contains microvascular endothelial cells, smooth muscle cells, and adipose stem cells. Containing substrates and are easily separable [Zuk et al., Tissue Eng 2001; 7: 211-228. These cells can be isolated from adipose tissue through enzymatic digestion and grow as Adipose Tissue-Derived Stem Cells (ADSCs) in certain culture environments that promote mesenchymal stem cell growth. Can be. Adipose tissue-derived adult stem cells have many properties including self-renewal capacity, long-term viability, and multilineage differentiation potential [Zuk et al. , Mol Biol Cell 2002; 13: 4279-4295, De Ugarte et al., Cells Tissues Organs 2003; 174: 101-109] It is possible to differentiate into osteoblasts, adipocytes, myoblasts, chondrocytes, etc. under certain conditions (growth factors, differentiation-inducing compounds, etc.) [Hauner et al. al., J Clin Endocrinol Metabol 1987; 64: 832-835, Grigoradis et al., J Cell Biol 1988; 106: 2139-2151. From this point of view, studies using adipose tissue-derived adult stem cells may be useful candidates for treating mesodermal defect repair or related diseases.

Recently, as various experiments using adult stem cells become active, the invention related to the culturing of adult stems is also progressing. When culturing adult stem cells, differentiated cells are spontaneously generated rather than stem cells in the process of cultivation to prevent the differentiation of other cells using a special medium composition. (European Patent No.1424338) discloses a technique of separating cultured stem cells using a column method to remove unwanted cells and recultivating only stem cells (US Pat. No. 5,566,750,5925567). number). In Korea, a method of maintaining continuity of stem cell culture by inventing a transporter generated during stem cell culture using the characteristics of a transporter included in stem cells has been invented (Korean Patent Publication No. 2005-00723349). In addition, mesenchymal stem cells are administered to animals to treat autoimmune diseases, allergic reactions, cancer or inflammatory diseases in animals, to promote wound healing (Korean Patent No. 2008-7025380), or micro-current Or an in vitro culture method of somatic replication embryos using a negative ion and a method of culturing embryonic stem cells (Korean Patent No. 0715366) and the like.

It is an object of the present invention to provide a method of regulating the growth of cells by establishing optimal exposure conditions of cold atmospheric pressure plasma that can promote or inhibit the growth of cells in cell culture.

In order to achieve the above object, the present invention provides a cell growth control method comprising the step of controlling the cold atmospheric pressure plasma exposure conditions of the cells in the cell culture.

The present invention is applied to the development of a device for the purpose of cell therapy, the establishment of safety criteria, the acceptable exposure range, etc. by establishing a low-temperature atmospheric pressure plasma exposure conditions that can promote or inhibit the growth of normal cells, stem cells, or cancer cells, etc. can do.

1 illustrates a low temperature atmospheric pressure plasma generating apparatus of the present invention.
2 shows a schematic diagram and a circuit of a low temperature atmospheric pressure plasma generating apparatus of the present invention.
Figure 3 shows the effect of cell growth according to the amount of cell culture medium in the cold atmospheric pressure plasma treatment of the present invention.
Figure 4 shows the effect of cell growth according to the exposure time in the cold atmospheric pressure plasma treatment of the present invention.
Figure 5 shows the effect of cell growth by input voltage at low temperature atmospheric pressure plasma treatment of the present invention.
Figure 6 shows the cell growth effect according to the gas inflow rate at low temperature atmospheric pressure plasma treatment of the present invention.
Figure 7 shows the effect of cell growth according to the distance between the exposed cells and the plasma source during the cold atmospheric pressure plasma treatment of the present invention.
8 and 9 show the effect of cell growth according to the number of times of plasma exposure in the low-temperature atmospheric pressure plasma treatment of the present invention.
Figure 10 shows the effect of inhibiting cancer cell growth in accordance with repeated exposure during the cold atmospheric pressure plasma treatment of the present invention.

EMBODIMENT OF THE INVENTION Hereinafter, the structure of this invention is demonstrated concretely.

The present invention relates to a method for regulating cell growth, comprising the step of controlling the cold atmospheric pressure plasma exposure conditions of the cells in the cell culture.

As used herein, the term "cold atmospheric pressure (atmospheric) plasma" is a relatively energy-stable and relatively energetic and stable action on the target object without a thermal change, thus changing the state of the interacting material or It has the advantage of not being damaged.

The apparatus for generating the low-temperature atmospheric pressure plasma is disclosed in FIGS. 1 and 2, and in the DBD (Dielectric Barrier Discharge) method using an AC power source, the base electrode is located inside a Teflon tube and surrounded by Teflon in the center of the tube. Another electrode is located. The discharge takes place in the space between the two electrodes and the distance between the two cylinders is 1 to 10 mm. The cylindrical discharge space is designed to allow air or discharge driving gas to pass through. AC power is applied to the electrode located in the center, frequency is 5 ~ 350 kHz, voltage is 1 ~ 20 kV in rms value.

The low temperature atmospheric pressure plasma generator is characterized by having the following applicable ranges:

Distance from plasma source: 2-5 cm

Standard liter per minute (slm): 0.2 slm or more

Source: Helium Gas (He gas)

Frequency: 20 kHz

Input voltage: 5-12 V

Output voltage: 6-20 kV

Cell growth control method of the present invention is characterized in that to promote or inhibit the growth of cells by controlling the plasma exposure conditions in the cell culture using the low temperature plasma generator.

The plasma exposure condition may include at least one of a gas inflow amount, an input voltage, an amount of cell culture medium, a plasma exposure time, a distance from a source, or a plasma exposure number.

The gas inflow amount refers to the inflow amount of the gas provided to the low-temperature atmospheric pressure plasma generator, and preferably the inflow amount of the helium gas.

In one embodiment, the gas inflow that can affect the growth regulation of normal cells, stem cells, cancer cells, etc. may be 0.5 to 5 slm.

The input voltage means a voltage applied to the low temperature atmospheric pressure plasma generator.

In one embodiment, the input voltage that may affect the growth regulation of normal cells may be 5-6V.

In one embodiment, the input voltage that may affect the growth regulation of stem cells may be 5 to 12V.

In one embodiment, the input voltage that can affect the growth regulation of cancer cells may be 1 to 12V.

The amount of the cell culture medium refers to the content of the medium provided to the cultured cells, and may be a medium used for culturing any one of normal cells, adult stem cells, or cancer cells. For example, it may be Dulbecco's modified Eagle's medium (DMEM), RMPI, or keratinocyte sphere-forming medium (SFM).

More specifically, normal cells such as fibroblasts (IMR90), and cancer cells such as human cervical cancer cells (HeLa), liver cancer cells (HepG2), osteosarcoma cancer cells (U2OS), contain 10% fetal calf serum and 1% antibiotic. DMEM medium can be used.

Pulmonary fibroblasts (WB8-VA13), colon cancer cells (HCT116), breast cancer cells (MDA-MB-231, etc.) can be cultured in RPMI medium containing 10% fetal calf serum and 1% antibiotics.

Adult stem cells may use keratinocyte SFM medium, which is a differentiation medium.

In one embodiment, the amount of cell culture medium that can affect cell growth regulation may be 0.5-1 mL per 1 × 10 ⁴ cells.

The distance from the source means the distance from the low temperature atmospheric pressure plasma generator to the cultured cells exposed. Preferably, the distance to the source may be 4 cm.

The plasma exposure time refers to the exposure time when the plasma is treated to the cultured cells once, and the number of plasma exposures refers to the number of repeated exposures of the plasma.

In one embodiment, the plasma exposure time that may affect the growth regulation of the cells may be from 60 seconds to 120 seconds in one treatment.

In one embodiment, the number of repeated plasma exposures that may affect the growth regulation of cells can be from 2 to 10 times between 1 minute and 2 minutes every 1 hour, or from 2 to 5 times every 2 minutes every 24 hours. have.

The cell growth control method of the present invention may control the growth conditions of low-temperature atmospheric pressure plasma to promote growth of normal cells or stem cells, or inhibit the growth of cancer cells. More preferably, the growth of normal cells, adult stem cells, or cancer cells of the human body can be controlled.

According to one embodiment, the helium gas flow rate is set at 0.5 to 5 slm (standard liter per minute), input voltage 5 to 6 V, distance 4 cm from the source, and the amount of normal cell culture medium is 1 × 10 ⁴ cells. 60 seconds to 120 seconds once adjusted to 0.5 to 1 mL per water, 2 to 10 plasma treatments for 1 minute to 2 minutes every 1 hour for repeated exposures or 2 to 5 times for 2 minutes every 24 hours It can promote the growth of normal cells.

In addition, according to one embodiment, the exposure conditions of the low-temperature atmospheric pressure plasma are set to helium gas inflow 0.5 to 5 slm, input voltage 5 to 12 V, distance 4 cm from the source, and the amount of stem cell culture medium is 1 ×. 20 to 120 seconds once, adjusted to 0.5 to 1 mL per 10 ⁴ cell number, 2 to 10 times for 1 minute to 2 minutes per hour for repeated exposures, or 2 to 5 times for 2 minutes every 24 hours By plasma treatment once can promote the growth of stem cells.

According to one embodiment, the exposure conditions of the low-temperature atmospheric pressure plasma are set to helium gas inflow 0.5 to 5 slm, input voltage 1 to 12 V, distance 4 cm from the source, and the amount of cancer cell culture medium is 1 × 10 ⁴ cells. 60 seconds to 120 times, adjusted to 0.5 to 1 mL per water, 2 to 10 times for 1 minute to 2 minutes per hour for repeated exposure, or 2 to 5 times for 2 minutes every 24 hours for repeated exposure It is possible to suppress the growth of cancer cells.

As described above, it can be used to promote or inhibit the growth of various cells by controlling the exposure conditions of the low-temperature atmospheric pressure in the cell culture, the development of a device for the purpose of cell therapy that can selectively control the growth of cells using the same It can be used for applications such as developing safety standards for developed devices and acceptable exposure ranges.

It will also provide a basis for studying mechanisms related to the growth of various cells following exposure to cold atmospheric plasma.

Hereinafter, the present invention will be described in more detail with reference to Examples of the present invention, but the scope of the present invention is not limited by the following Examples.

Preparation Example 1 Atmospheric Pressure Plasma device

Devices capable of generating plasma at atmospheric pressure (atmospheric pressure) using helium (He) gas are shown in FIGS. 1 and 2. More specifically described as follows.

The atmospheric plasma generator is a Dielectric Barrier Discharge (DBD) method using an AC power source. The ground electrode is located inside a Teflon tube, and another electrode surrounded by Teflon is located at the center of the tube. The discharge takes place in the space between the two electrodes and the distance between the two cylinders is 1 to 10 mm. The cylindrical discharge space is designed to allow air or discharge driving gas to pass through. AC power is applied to the electrode located in the center, frequency is 5 ~ 350 kHz and voltage is 1 ~ 20 kV in rms value.

Preparation Example 2 Isolation of Adipose Tissue-Derived Adult Stem Cells and Various Human Cell Cultures

Human adipose tissue was divided into 50 mL-tubes equally with PBS and shaken up and down to remove red blood cells between tissues.

The tissue was precipitated by centrifugation at 3,000 rpm for 3 minutes, and only the remaining tissue was divided into 50 mL-tubes, and PBS washing was repeated twice more. After tissue washing, 0.0075% collagenase XI dissolved in PBS was added to 50 mL-tubes in the same amount with adipose tissue, and the tissues were enzymatically digested for 1 hour while shaking at 37 ° C shaking incubator every 10 minutes.

After 1 hour, the decomposed adipose tissue was discarded by centrifugation, and only the remaining cells were put in DMEM medium containing 10% fetal calf serum, inactivated collagenase, and washed with PBS (10% (v / v) cultured in medium Dulbecco's modified Eagle's medium (DMEM) containing fetal bovine serum (FBS) and antibiotics (1%, 10 mL / L antibiotics).

After incubation for 24 hours, non-stick cells or erythrocytes were washed with PBS, loaded with a specialized medium capable of differentiation into stem cells (Keratinocyte SFM), and cultured in a 5% CO ₂ , 37 ° C. incubator.

Human cervical cancer cells (HeLa), liver cancer cells (HepG2), osteosarcoma cancer cells (U2OS), fibroblasts (IMR90) are cultured in DMEM (10% FBS, 1% antibiotics) medium and lung fibroblasts (WI38-VA13) , Colon cancer cells (HCT116), breast cancer cells (MDA-MB-231) were cultured in RPMI (10% FBS, 1% antibiotics).

Example 1 Low Temperature Atmospheric Pressure Plasma Treatment on Human Cells

Each 2 × 10 ⁴ cells were seeded in 35 mm dishes and incubated for 24 hours. After 24 hours, replace the cell culture with a new one, expose the plasma according to the plasma exposure conditions (input voltage, amount of cell culture, gas inflow, exposure time, distance from the source), and incubate for 12 hours. Was measured.

In order to confirm the effect of cell growth by repeated plasma generation, a plasma of 1 minute or 2 minutes at 5 slm He gas, 1 mL of cell culture medium, input voltage 5 V, and 4 cm away from the plasma source is used. After exposure, the cells were cultured for up to 9 hours, and MTT analysis or increased cell numbers were measured every 0, 1, 3, 6, and 9 hours to determine the effect of plasma on cell proliferation.

In addition, after exposing 2 minutes of plasma every 24 hours under the same conditions, the degree of cell proliferation was measured every 24 hours until 72 hours.

The MTT assay is a method for measuring mitochondrial dehydrogenase activity using a spectrophotometer using a yellowish chemical called 3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide (MTT). to be.

Cells of about 1 × 10 ⁴ cells / mL were placed on a 35 mm dish, incubated for 24 hours, exposed to low-temperature atmospheric plasma at different intensities and exposure times, and then MTT solution of 5 mg / mL concentration was added. The formazan product produced after time incubation was dissolved in 96-well and absorbance was measured in a microplate reader.

Experimental Example 1 Effect of Cell Growth According to Media Volume of Cell Culture Medium

In order for the generated atmospheric plasma to act directly on the cells, the effect must be passed through the cell culture medium or given a specific stimulus to the cell culture medium. In order to confirm the effect between the atmospheric pressure plasma and the cell culture medium, the amount of the cell culture medium was changed and the cells were exposed to the atmospheric pressure plasma to confirm the growth by MTT analysis.

More specifically, 1 × 10 ⁴ cells / mL cells were cultured in 35 mm dish 24 hours, the intracellular cultures were completely removed, and replaced with fresh culture medium to 0-2 mL in 0.5 mL units. A plasma of 5 slm was generated at 4 cm away from the dish and exposed to the cells for 1 minute, followed by MTT analysis after 12 hours of incubation. Cells containing 0 mL of the culture medium not exposed to atmospheric pressure were used as controls.

As shown in FIG. 3, the growth of human cervical cancer cells (HeLa), fibroblasts (IMR90), and adipose tissue-derived adult stem cells (ASC) in 0.5 mL and 1 mL of cultures was specifically observed. In mL, the growth of normal cells and stem cells was about 10-30% faster than that of cancer cells. 1 mL of culture medium with the largest growth change of all three cells was applied to all experiments.

Experimental Example 2 Effect of Cell Growth on Plasma Exposure Time

Plasma 0-180 seconds for cervical cancer cells (HeLa), fibroblasts (IMR90), and adipose tissue-derived adult stem cells (ASC) for 0-180 seconds to determine the growth effects over time of atmospheric plasma exposure to the cells. After exposure for 12 hours and cultured for 12 hours, cell growth effects were measured by MTT assay.

Plasma exposure conditions: 5 slm, 5 V, distance from source 4 cm, cell culture 1 mL

As shown in Figure 4, after 60 seconds, the growth of fibroblasts (IMR90) and adipose tissue-derived adult stem cells (ASC) increases. Three types of cell growth appeared to be the most different at 60 seconds and 120 seconds exposure conditions, and these exposure conditions were applied to all experiments.

Experimental Example 3 Effect of Cell Growth by Input Voltage

In order to determine how cancer cells, normal cells, and stem cells are affected by changes in the adjustable voltage (input voltage) during plasma generation, cell growth effects of 5-12 V voltage change were examined. Each cell was exposed to plasma with different input voltage for 1 minute and after 12 hours, cell growth change was confirmed by MTT analysis.

Plasma exposure conditions: 5 slm, distance from source 4 cm, cell culture 1 ml, exposure time 60 sec.

As shown in Figure 5, the voltage required to generate the plasma from the device of the present invention is adjustable above 5V. Plasma growth effect of plasma generated when the voltage was increased from 5 V to 12 V increased between normal cells (WI38-VA13) and stem cells (ASC) compared to human liver cancer cells (HepG2) between 5 and 6 V. It was confirmed that the increase.

Experimental Example 4 Effect of Cell Growth According to Gas Flow

In the present invention, the amount of inflow of helium gas capable of generating an atmospheric pressure plasma is 0.2 slm or more. In order to confirm the effect on the cell growth according to the gas inflow of 0.2-5 slm, plasma was generated while increasing the gas inflow, and cell growth was confirmed by MTT analysis. The effect of cell growth on the helium gas per minute (Slm; standard liter per minute) was confirmed.

Plasma exposure conditions: exposure time 1 min, 5 V, distance from source 4 cm, cell culture 1 mL.

As shown in FIG. 6, the growth of stem cells began to increase at 0.5 slm or more, and the growth of three kinds of cells was found to be different at 3 and 5 slm. It was applied to the next plasma exposure experiment on the basis of 5 slm.

Experimental Example 5 Effect of Cell Growth According to Distance from Cell and Plasma Source

In order to confirm the effect on cell growth according to the distance from the location where the plasma is generated, the cells were placed 2, 3, 4, 5 cm from the plasma source and the plasma was exposed for 1 minute. After incubation for 12 hours, cell growth was confirmed by MTT analysis.

Plasma exposure conditions: exposure time 1 min, 5 slm, 5 V, cell culture 1 mL.

As shown in FIG. 7, when the conditions exposed at a distance of 2 cm were 100%, the cell growth rate was 3 cm, 4 cm, compared to normal cells (IMR90) and stem cells (ASC) compared to cancer cells (HeLa). ) Growth seems to have increased. At 5 cm, there was no significant difference in the three cell growth rates.

Experimental Example 6 Effect of Cell Growth According to the Number of Plasma Exposures

In order to confirm the effect of repeated plasma exposure on the cell growth, exposure was increased for 2 minutes every 1 hour, and then cell growth was confirmed by MTT analysis after 0, 1, 3, 6, and 9 hours (FIG. 8). ). In addition, the growth of the cells after the plasma exposure for 2 minutes every 24 hours was confirmed through the number of cells (Fig. 9).

Plasma exposure conditions: 5 slm, 5 V, distance from source 4 cm, cell culture 1 mL, exposure time 2 min / 1h, 2 min / 24 h)

When plasma was treated to each cell for 2 minutes every hour (FIG. 8) and after exposure to cancer cells (HeLa), normal cells (IMR90) and stem cells (ASC) repeatedly for 2 minutes every 24 hours (FIG. 8) Comparing the results of 9), both results showed that the proliferation of cancer cells was suppressed and the proliferation of normal cells and stem cells was promoted. In particular, when the plasma treatment every 1 hour it can be seen that the cancer cells proliferation inhibitory effect appears relatively fast.

Experimental Example 7 Effects of Inhibiting Cancer Cell Growth According to the Number of Plasma Exposures

Four different types of cancer cells were used to confirm the cell growth inhibition effect seen in HeLa cells. After repeatedly exposing the plasma for 2 minutes every 1 hour (the same exposure conditions as FIG. 8), cell growth was measured by MTT analysis.

As shown in FIG. 10, plasma was exposed in 1 hour units using human colon cancer cell line (HCT116), liver cancer cell line (HepG2), breast cancer cell line (MDA-MB-231), and osteosarcoma cancer cell line (U2OS). Cell growth changes were confirmed by culturing for 9 hours, and when all the cancer cells were exposed to plasma, the cell growth inhibitory effect was about 15% or more compared to the control group after 3 hours.

Claims (8)

Cell growth control method comprising the step of controlling the cold atmospheric plasma exposure conditions of the cells in the cell culture.
The method of claim 1,
Low temperature atmospheric pressure plasma is a cell growth control method generated in the atmospheric pressure plasma generator of DBD (Dielectric Barrier Discharge) method using an AC power source.
The method of claim 1,
The cold atmospheric plasma exposure condition includes at least one of gas inflow rate, input voltage, amount of cell culture medium, plasma exposure time, distance from the source, or the number of plasma exposures.
The method of claim 3,
Cell culture medium is a method for regulating cell growth is a medium used for the culture of any of normal cells, stem cells, or cancer cells.
The method of claim 1,
Cell growth regulation is to promote the growth of normal cells or stem cells, or to inhibit the growth of cancer cells.
The method of claim 1,
The exposure conditions of the low-temperature atmospheric pressure plasma were set to 0.5 to 5 slm (standard liter per minute) of helium gas input, 5 to 6 V of input voltage, and 4 cm of distance from the source, and the amount of normal cell culture medium was 1 × 10 ⁴ cells. 60 seconds to 120 seconds once adjusted to 0.5 to 1 mL per water, 2 to 10 plasma treatments for 1 minute to 2 minutes every 1 hour for repeated exposures or 2 to 5 times for 2 minutes every 24 hours Cell growth control method for promoting the growth of normal cells.
The method of claim 1,
The exposure conditions of the low-temperature atmospheric pressure plasma were set at a helium gas inflow rate of 0.5 to 5 slm, an input voltage of 5 to 12 V, and a distance of 4 cm from the source, and the amount of stem cell culture medium was 0.5 to 1 mL per 1 × 10 ⁴ cells. Once 60 seconds to 120 seconds, repeated exposure 2 to 10 times for 1 minute to 2 minutes every hour, or 2 to 5 times for 2 minutes every 24 hours to control the growth of stem cells Promoting cell growth regulation.
The method of claim 1,
The exposure conditions of the low-temperature atmospheric pressure plasma were set at a helium gas inflow rate of 0.5 to 5 slm, an input voltage of 1 to 12 V, and a distance of 4 cm from the source, and the amount of the cancer cell culture medium was 0.5 to 1 mL per 1 × 10 ⁴ cells. Regulation of cell growth that inhibits the growth of cancer cells once every 60 seconds to 120 seconds, in the case of repeated exposure, 1 to 2 minutes every 1 hour to 2 minutes every 2 hours, or 2 to 5 times every 2 minutes every 24 hours Way.

Images